• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去甲肾上腺素转运体基因rs2242446和rs5669位点多态性与抑郁症之间的关联。

Association between polymorphism of the norepinephrine transporter gene rs2242446 and rs5669 loci and depression disorders.

作者信息

Pan Yu, Cheng Qi, Shan Mo-Shui, Yan Jin

机构信息

Department of Psychology and Mental Health, Second Military Medical UniversityShanghai, China; Department of Medical Psychology, General Hospital of PLABeijing, China.

Department of Juvenile and Children's Behavioral Medicine, 102 Hospital of PLA Changzhou, China.

出版信息

Int J Clin Exp Med. 2015 Oct 15;8(10):18837-42. eCollection 2015.

PMID:26770504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4694404/
Abstract

OBJECTIVE

To explore the association between polymorphism of the norepinephrine transporter (NET) gene rs2242446 and rs5669 loci and depression in Chinese Han population.

METHODS

A case-control study was carried out, the gene types and allele distributions of NFT gene rs2242446 and rs5569 loci in 302 depression patients and 302 healthy controls were detected by Taqman SNP genotyping technology.

RESULTS

The gene types and allele frequency distributions of NFT gene rs2242446 and rs5569 loci had significant differences between case group and control group (rs2242446, x(2)=26.045, P<0.05, x(2)=8.827, P<0.05, rs5569, x(2)=42.47, P<0.05, x(2)=20.9, P<0.05). The CC genotype of NET gene rs2242446 locus and rs5569 loci was a protective factor of depression compared with the CT and TT genotypes.

CONCLUSION

The NET genepoly morphism of rs2242446 and rs5569 loci was a ssociated with depression in Chinese Han population, in which the CC genotype of rs2242446 and rs5569 loci was a protective factor of depression.

摘要

目的

探讨去甲肾上腺素转运体(NET)基因rs2242446和rs5669位点多态性与中国汉族人群抑郁症的关系。

方法

进行病例对照研究,采用Taqman SNP基因分型技术检测302例抑郁症患者和302例健康对照者中NFT基因rs2242446和rs5569位点的基因类型和等位基因分布。

结果

病例组与对照组在NFT基因rs2242446和rs5569位点的基因类型和等位基因频率分布存在显著差异(rs2242446,x(2)=26.045,P<0.05,x(2)=8.827,P<0.05;rs5569,x(2)=42.47,P<0.05,x(2)=20.9,P<0.05)。与CT和TT基因型相比,NET基因rs2242446位点和rs5569位点的CC基因型是抑郁症的保护因素。

结论

NET基因rs2242446和rs5569位点多态性与中国汉族人群抑郁症相关,其中rs2242446和rs5569位点的CC基因型是抑郁症的保护因素。

相似文献

1
Association between polymorphism of the norepinephrine transporter gene rs2242446 and rs5669 loci and depression disorders.去甲肾上腺素转运体基因rs2242446和rs5669位点多态性与抑郁症之间的关联。
Int J Clin Exp Med. 2015 Oct 15;8(10):18837-42. eCollection 2015.
2
The norepinephrine transporter gene is associated with the retardation symptoms of major depressive disorder in the Han Chinese population.去甲肾上腺素转运体基因与汉族人群中重度抑郁症的迟缓症状相关。
Neural Regen Res. 2012 Sep 5;7(25):1985-91. doi: 10.3969/j.issn.1673-5374.2012.25.010.
3
Meta-analysis on the Association Between Norepinephrine Transporter Gene rs2242446, rs5569 Polymorphisms and Risk of Major Depressive Disorder.去甲肾上腺素转运体基因 rs2242446、rs5569 多态性与重度抑郁症发病风险的 Meta 分析。
Arch Med Res. 2018 May;49(4):261-269. doi: 10.1016/j.arcmed.2018.08.010. Epub 2018 Oct 3.
4
The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population.去甲肾上腺素转运体基因与负性生活事件在中国汉族人群重度抑郁症中的联合作用。
J Neural Transm (Vienna). 2008 Dec;115(12):1681-6. doi: 10.1007/s00702-008-0109-5. Epub 2008 Sep 9.
5
Association between T-182C, G1287A polymorphism in NET gene and suicidality in major depressive disorder in Chinese patients.NET 基因 T-182C、G1287A 多态性与中国抑郁症患者自杀的相关性。
Int J Psychiatry Clin Pract. 2018 Nov;22(4):304-309. doi: 10.1080/13651501.2017.1406121. Epub 2018 Apr 27.
6
Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder.去甲肾上腺素转运体基因(SLC6A2)多态性与重度抑郁症患者自杀之间的关联。
J Affect Disord. 2014 Apr;158:127-32. doi: 10.1016/j.jad.2014.01.018. Epub 2014 Feb 11.
7
Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study.儿童期虐待持续的情绪影响及去甲肾上腺素转运体基因变异对重度抑郁症抗抑郁疗效的作用:一项初步研究
Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):53-61. doi: 10.9758/cpn.2015.13.1.53.
8
Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.去甲肾上腺素转运体基因多态性与 ADHD 患者哌甲酯反应的相关性分析。
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt A):122-128. doi: 10.1016/j.pnpbp.2018.01.013. Epub 2018 Feb 20.
9
Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis.去甲肾上腺素转运体基因 T-182C 和 G1287A 多态性与重性抑郁障碍的相关性:一项荟萃分析。
J Affect Disord. 2013 Aug 15;150(1):23-8. doi: 10.1016/j.jad.2013.03.016. Epub 2013 May 4.
10
Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups.去甲肾上腺素转运体基因多态性T-182C和G1287A与酒精依赖及其临床亚组无关。
Drug Alcohol Depend. 2008 Jan 1;92(1-3):20-6. doi: 10.1016/j.drugalcdep.2007.06.003. Epub 2007 Jul 13.

引用本文的文献

1
Pharmacogenetics and the Response to Antidepressants in Major Depressive Disorder.药物遗传学与重度抑郁症中对抗抑郁药的反应
Pharmaceuticals (Basel). 2025 Sep 11;18(9):1360. doi: 10.3390/ph18091360.
2
Associations Among Monoamine Neurotransmitter Pathways, Personality Traits, and Major Depressive Disorder.单胺神经递质通路、人格特质与重度抑郁症之间的关联。
Front Psychiatry. 2020 May 13;11:381. doi: 10.3389/fpsyt.2020.00381. eCollection 2020.
3
Reduction of depression-like behavior in rat model induced by ShRNA targeting norepinephrine transporter in locus coeruleus.通过靶向蓝斑去甲肾上腺素转运体的短发夹 RNA 降低大鼠模型中的抑郁样行为。
Transl Psychiatry. 2020 May 4;10(1):130. doi: 10.1038/s41398-020-0808-8.

本文引用的文献

1
5-HTTLPR genotype potentiates the effects of war zone stressors on the emergence of PTSD, depressive and anxiety symptoms in soldiers deployed to iraq.5-羟色胺转运体基因多态性(5-HTTLPR)增强了战区应激源对部署到伊拉克的士兵创伤后应激障碍(PTSD)、抑郁和焦虑症状出现的影响。
World Psychiatry. 2015 Jun;14(2):198-206. doi: 10.1002/wps.20215.
2
Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.基于液相色谱-质谱联用技术的重度抑郁症分类血浆生物标志物的发现与验证
J Proteome Res. 2015 May 1;14(5):2322-30. doi: 10.1021/acs.jproteome.5b00144. Epub 2015 Mar 26.
3
Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.血清素转运体(5-HTTLPR)和去甲肾上腺素转运体(NET)基因多态性:难治性抑郁症中电休克治疗的易感性及治疗反应
Neurosci Lett. 2015 Mar 17;590:116-20. doi: 10.1016/j.neulet.2015.01.077. Epub 2015 Feb 1.
4
The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population.去甲肾上腺素转运体基因与负性生活事件在中国汉族人群重度抑郁症中的联合作用。
J Neural Transm (Vienna). 2008 Dec;115(12):1681-6. doi: 10.1007/s00702-008-0109-5. Epub 2008 Sep 9.
5
Pharmacogenetics in mood disorder.情绪障碍中的药物遗传学
Curr Opin Psychiatry. 2005 Jan;18(1):33-9.
6
Effect of antidepressant drugs in mice lacking the norepinephrine transporter.抗抑郁药物对缺乏去甲肾上腺素转运体的小鼠的影响。
Neuropsychopharmacology. 2006 Nov;31(11):2424-32. doi: 10.1038/sj.npp.1301064. Epub 2006 Mar 22.
7
[Depression, a widespread disease. Epidemiology, care situation, diagnosis, therapy and prevention].
Dtsch Med Wochenschr. 2006 Jan 5;131(1-2):35-40. doi: 10.1055/s-2006-924919.
8
Comorbid major depression and panic disorder: significance of temporal sequencing to familial transmission.共病的重度抑郁症和惊恐障碍:时间顺序对家族遗传的意义。
J Affect Disord. 2004 Oct 1;82(1):119-23. doi: 10.1016/j.jad.2003.08.008.
9
Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.去甲肾上腺素转运体基因多态性对米那普明抗抑郁反应的预测作用
Am J Psychiatry. 2004 Sep;161(9):1575-80. doi: 10.1176/appi.ajp.161.9.1575.
10
A case-control and family-based association study of the 5-HTTLPR in pediatric-onset depressive disorders.一项关于儿童期起病的抑郁症中5-羟色胺转运体基因连锁多态性区域(5-HTTLPR)的病例对照及基于家系的关联研究。
Biol Psychiatry. 2004 Aug 15;56(4):292-5. doi: 10.1016/j.biopsych.2004.05.018.